Clinical Trial Update: Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intracavitary injection of human umbilical cord mesenchymal stem cells (hUMSCs) for acute basal ganglia hematoma after stereot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Ganglia Hematoma

Drugs mentioned

• HUMSCs (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Basal Ganglia Hematoma | Phase 2 | Status: UNKNOWN